Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program: Correlation With OutcomesMETRA, Marco; COTTER, Gad; DOROBANTU, Maria I et al.Journal of the American College of Cardiology. 2013, Vol 61, Num 2, pp 196-206, issn 0735-1097, 11 p.Article

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialTEERLINK, John R; COTTER, Gad; DOROBANTU, Maria I et al.Lancet (British edition). 2013, Vol 381, Num 9860, pp 29-39, issn 0140-6736, 11 p.Article